Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-26-036998
Filing Date
2026-08-11
Accepted
2026-08-11 08:45:41
Documents
17
Period of Report
2026-08-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm   iXBRL DEF 14A 927965
2 GRAPHIC formdef14a_001.jpg GRAPHIC 4101
3 GRAPHIC proxy_001.jpg GRAPHIC 474419
4 GRAPHIC proxy_002.jpg GRAPHIC 395422
  Complete submission text file 0001493152-26-036998.txt   3623681

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cdt-20251231.xsd EX-101.SCH 3415
6 XBRL DEFINITION FILE cdt-20251231_def.xml EX-101.DEF 3366
7 XBRL LABEL FILE cdt-20251231_lab.xml EX-101.LAB 53135
8 XBRL PRESENTATION FILE cdt-20251231_pre.xml EX-101.PRE 41979
20 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 3326
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CDT Equity Inc. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41245 | Film No.: 261260787
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)